Yüklüyor......
Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
Conventional therapeutic approaches for advanced prostate cancer - such as androgen deprivation, chemotherapy, radiation - come up often against lack of effectiveness because of possible arising of correlative cancer cell resistance and/or inadequate anti-tumor immune conditions. Whence the timeline...
Kaydedildi:
| Yayımlandı: | G Chir |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
CIC Edizioni Internazionali
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256907/ https://ncbi.nlm.nih.gov/pubmed/28098061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11138/gchir/2016.37.5.225 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|